| 1 | [SID17507741] | Active | Potency | 14.581 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 2 | [SID17507741] | Active | Potency | 14.581 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 3 | [SID17507741] | Active | Potency | 14.581 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 4 | [SID17507741] | Active | Potency | 14.581 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 5 | [SID17507741] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID17507741] | Active | | | Screen for Chemicals that Extend Yeast Lifespan [AID775, Type: screening] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Active | | BioAssay | Screen for Chemicals that Extend Yeast Lifespan | | AID | 775 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17507741] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 8 | [SID17507741] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID17507741] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 10 | [SID17507741] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 11 | [SID17507741] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 12 | [SID17507741] | Inactive | Potency | 0.1122 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 0.1122 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 13 | [SID17507741] | Inactive | Potency | 3.9811 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 14 | [SID17507741] | Inactive | Potency | 3.9811 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 15 | [SID17507741] | Inactive | Potency | 5.2213 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 5.2213 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17507741] | Inactive | Potency | 28.1838 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 17 | [SID17507741] | Inactive | Potency | 28.1838 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 18 | [SID17507741] | Inactive | Potency | 28.1838 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 19 | [SID17507741] | Inactive | Potency | 89.1251 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 20 | [SID17507741] | Inactive | Potency | 89.1251 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 21 | [SID17507741] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 22 | [SID17507741] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 23 | [SID17507741] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 24 | [SID17507741] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 25 | [SID17507741] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 26 | [SID17507741] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 27 | [SID17507741] | Inactive | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 28 | [SID17507741] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 29 | [SID17507741] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 30 | [SID17507741] | Inactive | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 31 | [SID17507741] | Inactive | | | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening] | Valosin-containing protein [Homo sapiens] [gi:111305821] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition | | AID | 1481 | | BioAssay type | screening | | Target | Valosin-containing protein [Homo sapiens] [gi:111305821] | | PubMed | | | Data Table |  |
|
| 32 | [SID17507741] | Inactive | | | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening] | Valosin-containing protein [Homo sapiens] [gi:111305821] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition | | AID | 1481 | | BioAssay type | screening | | Target | Valosin-containing protein [Homo sapiens] [gi:111305821] | | PubMed | | | Data Table |  |
|
| 33 | [SID17507741] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID17507741] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID17507741] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 36 | [SID17507741] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 37 | [SID17507741] | Inactive | | | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 [AID540277, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 | | AID | 540277 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 38 | [SID17507741] | Inactive | | | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 [AID540277, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 | | AID | 540277 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 39 | [SID17507741] | Inactive | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 40 | [SID17507741] | Inactive | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 41 | [SID17507741] | Inactive | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 42 | [SID17507741] | Inactive | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 43 | [SID17507741] | Inactive | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 44 | [SID17507741] | Inactive | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 45 | [SID17507741] | Inactive | Potency | | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 46 | [SID17507741] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 47 | [SID17507741] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 48 | [SID17507741] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 49 | [SID17507741] | Inactive | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 50 | [SID17507741] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17507741 | | CID | 54681789 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|